Related Experiment Videos

Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1

Nelson S Winkler1, Margherita Milone2, Jennifer M Martinez-Thompson2

  • 1Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States.

Abstract

Insights

Fuchs' endothelial corneal dystrophy (FECD) is common in myotonic dystrophy type 1 (DM1) families and appears linked to DMPK gene CTG repeat expansion, not TCF4 expansion.

Area of Science:

  • Genetics
  • Ophthalmology
  • Neurology

Background:

  • RNA toxicity from CTG trinucleotide repeat (TNR) expansion in TCF4 and DMPK genes is implicated in Fuchs' endothelial corneal dystrophy (FECD) and myotonic dystrophy type 1 (DM1).
  • Understanding the genetic basis of FECD in DM1 patients is crucial for diagnosis and management.

Purpose of the Study:

  • To investigate the prevalence of phenotypic FECD in DM1 patients and their families.
  • To analyze CTG repeat expansion in the TCF4 gene and DMPK gene expression in corneal endothelium of DM1 patients.

Main Methods:

  • Slit lamp biomicroscopy was used to evaluate FECD grade in 26 participants from 14 DM1 families.
  • CTG TNR length in TCF4 and DMPK was determined using Gene Scan and Southern blotting of peripheral blood leukocyte DNA.

Main Results:

  • FECD (grade ≥2) was observed in 36% of DM1 probands, significantly higher than the general population (5%).
  • FECD segregated with DM1 within families; however, TCF4 TNR expansion was absent in all DM1 subjects analyzed.
  • DM1 severity and DMPK TNR length did not predict FECD presence in DM1 patients.

Conclusions:

  • FECD is prevalent in DM1 families and cosegregates with the disease.
  • The absence of TCF4 TNR expansion in DM1 families suggests it is not the cause of FECD in this cohort.
  • These findings support the hypothesis that DMPK TNR expansion contributes to FECD development in DM1 patients.

Related Concept Videos